Dermata Therapeutics, Inc. (DRMA) ownership: Top institutional holder: GEODE CAPITAL MANAGEMENT, LLC ($58483.00). Insider activity: Net Seller (1 buys, 19 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 48334.00 | $58483.00 | 2026-03-31 |
| UBS Group AG | 35608.00 | $43085.00 | 2026-03-31 |
| Clear Street Group Inc. | 17000.00 | $39440.00 | 2025-12-31 |
| Welch & Forbes LLC | 20000.00 | $24200.00 | 2026-03-31 |
| BANK OF AMERICA CORP /DE/ | 3457.00 | $8020.00 | 2025-12-31 |
| WELLS FARGO & COMPANY/MN | 2000.00 | $2160.00 | 2025-03-31 |
| MCF Advisors LLC | 1732.00 | $2096.00 | 2026-03-31 |
| JPMORGAN CHASE & CO | 696.00 | $1615.00 | 2025-12-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-08-16 | |
| Sell | null | 2026-08-16 | |
| Sell | null | 2026-06-16 | |
| Buy | null | 2026-02-17 | |
| Sell | null | 2026-01-02 | |
| Sell | null | 2026-01-02 | |
| Sell | null | 2026-01-02 | |
| Sell | null | 2026-01-02 |
Back to DRMA overview · DRMA earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.